LISATA THERAPEUTICS, INC. Research and Development Expense
LISATA THERAPEUTICS, INC. (LSTA) reported Research and Development Expense of $3.24 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2022-08-04
- LISATA THERAPEUTICS, INC. research and development expense for the quarter ending 2022-06-30 was $3.24M, a 25.18% decline year-over-year.
- LISATA THERAPEUTICS, INC. research and development expense for the quarter ending 2022-03-31 was $3.28M, a 35.42% decline year-over-year.
- LISATA THERAPEUTICS, INC. research and development expense for the quarter ending 2021-12-31 was $4.15M, a 42.76% increase year-over-year.
- LISATA THERAPEUTICS, INC. research and development expense for the quarter ending 2021-09-30 was $4.13M, a 36.18% increase year-over-year.
- LISATA THERAPEUTICS, INC. research and development expense for fiscal 2021 was $17.68M, a 91.07% increase from fiscal 2020.
- LISATA THERAPEUTICS, INC. research and development expense for fiscal 2020 was $9.25M, a 14.30% decline from fiscal 2019.
- LISATA THERAPEUTICS, INC. research and development expense for fiscal 2019 was $10.80M, a 42.18% increase from fiscal 2018.
- LISATA THERAPEUTICS, INC. research and development expense for fiscal 2018 was $7.59M, a 52.07% decline from fiscal 2017.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-06-30 | $3.24M 10-Q · filed 2022-08-04 | $6.52M 10-Q · filed 2022-08-04 | $10.67M derived: sum of 3 quarters · filed 2022-08-04 | $14.79M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2022-03-31 | $3.28M 10-Q · filed 2022-05-05 | $7.43M derived: sum of 2 quarters · filed 2022-05-05 | $11.55M derived: sum of 3 quarters · filed 2022-05-05 | $15.88M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-12-31 | $4.15M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $8.28M derived: sum of 2 quarters · filed 2022-03-22 | $12.60M derived: sum of 3 quarters · filed 2022-08-04 | $17.68M 10-K · filed 2022-03-22 | ||||
| 2021-09-30 | $4.13M 10-Q · filed 2021-11-04 | $8.45M derived: sum of 2 quarters · filed 2022-08-04 | $13.53M 10-Q · filed 2021-11-04 | $16.44M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-06-30 | $4.33M 10-Q · filed 2022-08-04 | $9.40M 10-Q · filed 2022-08-04 | $12.31M derived: sum of 3 quarters · filed 2022-08-04 | $15.34M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $5.08M 10-Q · filed 2022-05-05 | $7.98M derived: sum of 2 quarters · filed 2022-05-05 | $11.01M derived: sum of 3 quarters · filed 2022-05-05 | $12.83M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $5.94M derived: sum of 2 quarters · filed 2022-03-22 | $7.75M derived: sum of 3 quarters · filed 2022-03-22 | $9.25M 10-K · filed 2022-03-22 | ||||
| 2020-09-30 | $3.03M 10-Q · filed 2021-11-04 | $4.85M derived: sum of 2 quarters · filed 2021-11-04 | $6.35M 10-Q · filed 2021-11-04 | $9.11M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $1.82M 10-Q · filed 2021-08-05 | $3.32M 10-Q · filed 2021-08-05 | $6.08M derived: sum of 3 quarters · filed 2021-08-05 | $9.09M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $1.50M 10-Q · filed 2021-05-06 | $4.27M derived: sum of 2 quarters · filed 2021-05-06 | $7.27M derived: sum of 3 quarters · filed 2021-05-06 | $10.26M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $5.77M derived: sum of 2 quarters · filed 2021-02-25 | $8.76M derived: sum of 3 quarters · filed 2021-02-25 | $10.80M 10-K · filed 2021-02-25 | ||||
| 2019-09-30 | $3.00M 10-Q · filed 2020-11-05 | $5.99M derived: sum of 2 quarters · filed 2020-11-05 | $8.03M 10-Q · filed 2020-11-05 | $9.54M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $2.99M 10-Q · filed 2020-08-13 | $5.03M 10-Q · filed 2020-08-13 | $6.53M derived: sum of 3 quarters · filed 2020-08-13 | $8.23M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $2.04M 10-Q · filed 2020-05-07 | $3.55M derived: sum of 2 quarters · filed 2020-05-07 | $5.25M derived: sum of 3 quarters · filed 2020-05-07 | $7.37M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $3.21M derived: sum of 2 quarters · filed 2020-03-05 | $5.33M derived: sum of 3 quarters · filed 2020-03-05 | $7.59M 10-K · filed 2020-03-05 | ||||
| 2018-09-30 | $1.70M 10-Q · filed 2019-11-06 | $1.70M 10-Q · filed 2018-11-08 | $3.82M derived: sum of 2 quarters · filed 2019-11-06 | $6.09M 10-Q · filed 2019-11-06 | $6.09M 10-Q · filed 2018-11-08 | $10.74M derived: sum of 4 quarters · filed 2019-11-06 | ||
| 2018-06-30 | $2.12M 10-Q · filed 2019-08-08 | $2.12M 10-Q · filed 2018-08-09 | $4.38M 10-Q · filed 2019-08-08 | $4.38M 10-Q · filed 2018-08-09 | $9.04M derived: sum of 3 quarters · filed 2019-08-08 | $12.22M derived: sum of 4 quarters · filed 2019-08-08 | ||
| 2018-03-31 | $2.26M 10-Q · filed 2019-05-09 | $2.26M 10-Q · filed 2018-05-10 | $6.91M derived: sum of 2 quarters · filed 2019-05-09 | $10.10M derived: sum of 3 quarters · filed 2019-05-09 | $14.38M derived: sum of 4 quarters · filed 2019-05-09 | |||
| 2017-12-31 | $4.65M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $7.84M derived: sum of 2 quarters · filed 2019-03-14 | $12.12M derived: sum of 3 quarters · filed 2019-03-14 | $15.84M 10-K · filed 2019-03-14 | $15.84M 10-K · filed 2018-03-22 | |||
| 2017-09-30 | $3.19M 10-Q · filed 2018-11-08 | $7.46M derived: sum of 2 quarters · filed 2018-11-08 | $11.19M 10-Q · filed 2018-11-08 | $14.39M derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $4.28M 10-Q · filed 2018-08-09 | $8.00M 10-Q · filed 2018-08-09 | $11.21M derived: sum of 3 quarters · filed 2018-08-09 | $14.17M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $3.73M 10-Q · filed 2018-05-10 | $3.46M 10-Q · filed 2017-05-15 | $6.93M derived: sum of 2 quarters · filed 2018-05-10 | $9.89M derived: sum of 3 quarters · filed 2018-05-10 | $14.38M derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2016-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $6.16M derived: sum of 2 quarters · filed 2018-03-22 | $10.65M derived: sum of 3 quarters · filed 2018-03-22 | $16.70M 10-K · filed 2018-03-22 | $15.11M 10-K · filed 2017-03-17 | |||
| 2016-09-30 | $2.96M 10-Q · filed 2017-11-09 | $2.63M 10-Q · filed 2016-11-07 | $7.45M derived: sum of 2 quarters · filed 2017-11-09 | $13.50M 10-Q · filed 2017-11-09 | $12.53M 10-Q · filed 2016-11-07 | $16.50M derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2016-06-30 | $4.49M 10-Q · filed 2017-08-10 | $4.03M 10-Q · filed 2016-08-09 | $10.54M 10-Q · filed 2017-08-10 | $9.90M 10-Q · filed 2016-08-09 | $13.54M derived: sum of 3 quarters · filed 2017-08-10 | $19.86M derived: sum of 4 quarters · filed 2017-08-10 | ||
| 2016-03-31 | $5.88M 10-Q · filed 2017-05-15 | $9.06M derived: sum of 2 quarters · filed 2017-05-15 | $15.37M derived: sum of 3 quarters · filed 2017-05-15 | $22.97M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | $3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | $9.49M derived: sum of 2 quarters · filed 2017-03-17 | $17.10M derived: sum of 3 quarters · filed 2017-03-17 | $23.90M 10-K · filed 2017-03-17 | ||||
| 2015-09-30 | $6.32M 10-Q · filed 2016-11-07 | $13.92M derived: sum of 2 quarters · filed 2016-11-07 | $20.72M 10-Q · filed 2016-11-07 | $30.89M derived: sum of 4 quarters · filed 2016-11-07 | ||||
| 2015-06-30 | $7.60M 10-Q · filed 2016-08-09 | $14.40M 10-Q · filed 2016-08-09 | $24.57M derived: sum of 3 quarters · filed 2016-08-09 | $33.04M derived: sum of 4 quarters · filed 2016-08-09 | ||||
| 2015-03-31 | $6.80M 10-Q · filed 2016-05-05 | $16.97M derived: sum of 2 quarters · filed 2016-05-05 | $25.44M derived: sum of 3 quarters · filed 2016-05-05 | $31.24M derived: sum of 4 quarters · filed 2016-05-05 | ||||
| 2014-12-31 | $10.17M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $18.64M derived: sum of 2 quarters · filed 2016-03-15 | $24.44M derived: sum of 3 quarters · filed 2016-03-15 | $29.19M 10-K · filed 2016-03-15 | ||||
| 2014-09-30 | $8.47M 10-Q · filed 2015-11-05 | $14.27M derived: sum of 2 quarters · filed 2015-11-05 | $19.02M 10-Q · filed 2015-11-05 | $24.32M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-06-30 | $5.80M 10-Q · filed 2015-08-06 | $10.55M 10-Q · filed 2015-08-06 | $15.85M derived: sum of 3 quarters · filed 2016-03-15 | $20.34M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-03-31 | $4.76M 10-Q · filed 2015-05-06 | $10.06M derived: sum of 2 quarters · filed 2016-03-15 | $14.54M derived: sum of 3 quarters · filed 2016-03-15 | $18.52M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | $5.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $9.78M derived: sum of 2 quarters · filed 2016-03-15 | $13.76M derived: sum of 3 quarters · filed 2016-03-15 | $16.92M 10-K · filed 2016-03-15 | ||||
| 2013-09-30 | $4.49M 10-Q · filed 2014-10-30 | $8.46M derived: sum of 2 quarters · filed 2014-10-30 | $11.62M 10-Q · filed 2014-10-30 | $14.58M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | $3.97M 10-Q · filed 2014-08-07 | $7.13M 10-Q · filed 2014-08-07 | $10.09M derived: sum of 3 quarters · filed 2015-03-02 | $12.92M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | $3.16M 10-Q · filed 2014-05-08 | $6.12M derived: sum of 2 quarters · filed 2015-03-02 | $8.95M derived: sum of 3 quarters · filed 2015-03-02 | $11.67M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $5.79M derived: sum of 2 quarters · filed 2015-03-02 | $8.50M derived: sum of 3 quarters · filed 2015-03-02 | $10.45M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | $2.83M 10-Q · filed 2013-11-07 | $5.54M derived: sum of 2 quarters · filed 2013-11-07 | $7.49M 10-Q · filed 2013-11-07 | $9.55M derived: sum of 4 quarters · filed 2013-11-07 | ||||
| 2012-06-30 | $2.71M 10-Q · filed 2013-08-08 | $4.66M 10-Q · filed 2013-08-08 | $6.73M derived: sum of 3 quarters · filed 2013-08-08 | $8.27M derived: sum of 4 quarters · filed 2013-08-08 | ||||
| 2012-03-31 | $1.95M 10-Q · filed 2013-05-09 | $2.71M 10-Q · filed 2012-05-11 | $4.01M derived: sum of 2 quarters · filed 2013-05-09 | $5.55M derived: sum of 3 quarters · filed 2013-05-09 | $7.14M derived: sum of 4 quarters · filed 2013-05-09 | |||
| 2011-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $3.60M derived: sum of 2 quarters · filed 2013-03-11 | $5.20M derived: sum of 3 quarters · filed 2013-03-11 | $7.72M 10-K · filed 2013-03-11 | $11.00M 10-K · filed 2012-03-20 | |||
| 2011-09-30 | $1.54M 10-Q · filed 2012-11-13 | $2.48M 10-Q · filed 2011-11-10 | $3.13M derived: sum of 2 quarters · filed 2012-11-13 | $5.66M 10-Q · filed 2012-11-13 | $7.77M 10-Q · filed 2011-11-10 | $6.78M derived: sum of 4 quarters · filed 2012-11-13 | ||
| 2011-06-30 | $1.59M 10-Q · filed 2012-08-14 | $2.37M 10-Q · filed 2011-08-12 | $4.12M 10-Q · filed 2012-08-14 | $5.28M 10-Q · filed 2011-08-12 | $5.24M derived: sum of 3 quarters · filed 2012-08-15 | $6.92M derived: sum of 4 quarters · filed 2012-08-15 | ||
| 2011-03-31 | $2.76M 10-Q · filed 2012-05-11 | $3.65M derived: sum of 2 quarters · filed 2012-08-15 | $5.33M derived: sum of 3 quarters · filed 2012-08-15 | $7.46M derived: sum of 4 quarters · filed 2012-08-15 | ||||
| 2010-12-31 | $894.80K derived: 8-K 12 month − 10-Q 9 month · filed 2012-08-15 | $2.57M derived: sum of 2 quarters · filed 2012-08-15 | $4.71M derived: sum of 3 quarters · filed 2012-08-15 | $6.01M 8-K · filed 2012-08-15 | $7.68M 10-K · filed 2012-03-20 | |||
| 2010-09-30 | $1.68M 10-Q · filed 2011-11-10 | $3.81M derived: sum of 2 quarters · filed 2011-11-10 | $5.11M 10-Q · filed 2011-11-10 | |||||
| 2010-06-30 | $2.13M 10-Q · filed 2011-08-12 | $3.43M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |